United Therapeutics Corporation shares owned by Krensavage Asset Management
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Krensavage Asset Management
from 13F filings
Historical chart of Krensavage Asset Management investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Krensavage Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Krensavage Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $44M | 201k | 219.89 |
| 2023-09-30 | $45M | 201k | 225.87 |
| 2023-06-30 | $45M | 203k | 220.75 |
| 2023-03-31 | $45M | 202k | 223.96 |
| 2022-12-31 | $53M | 192k | 278.09 |
| 2022-09-30 | $42M | 200k | 209.38 |
| 2022-06-30 | $47M | 201k | 235.64 |
| 2022-03-31 | $36M | 202k | 179.41 |
| 2021-12-31 | $44M | 205k | 216.08 |
| 2021-09-30 | $38M | 207k | 184.58 |
| 2021-06-30 | $39M | 220k | 179.41 |
| 2021-03-31 | $42M | 249k | 167.27 |
| 2020-12-31 | $49M | 323k | 151.79 |
| 2020-09-30 | $43M | 43k | 1000.00 |
| 2020-06-30 | $57M | 473k | 121.00 |
| 2020-03-31 | $51M | 540k | 94.83 |
| 2019-12-31 | $41M | 461k | 88.08 |
| 2019-09-30 | $43M | 540k | 79.75 |
| 2019-06-30 | $43M | 550k | 78.06 |
| 2019-03-31 | $59M | 505k | 117.37 |
| 2018-12-31 | $57M | 493k | 115.93 |
| 2018-09-30 | $62M | 486k | 127.88 |
| 2018-06-30 | $63M | 552k | 113.15 |
| 2018-03-31 | $74M | 654k | 112.36 |
| 2017-12-31 | $44M | 294k | 147.95 |
| 2017-09-30 | $41M | 347k | 117.19 |
| 2017-06-30 | $35M | 273k | 129.73 |
| 2017-03-31 | $32M | 235k | 135.38 |
| 2016-12-31 | $39M | 271k | 143.43 |
| 2016-09-30 | $33M | 276k | 118.08 |
| 2016-06-30 | $29M | 275k | 105.92 |
| 2016-03-31 | $25M | 223k | 111.43 |
| 2015-12-31 | $34M | 215k | 156.61 |
| 2015-09-30 | $26M | 200k | 131.24 |
| 2015-06-30 | $26M | 149k | 173.95 |
| 2015-03-31 | $23M | 131k | 172.44 |
| 2014-12-31 | $16M | 125k | 129.49 |
More positions owned by Krensavage Asset Management
View all positions for Krensavage Asset Management
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation